《大行報告》美銀證券首予建發國際(01908.HK)「買入」評級看26元 國營內房市佔贏家
美銀證券發表報告指出,在國企市場份額持續快速增長的趨勢下,建發國際(01908.HK)作為一家合同銷售強勁、市場份額快速增長的國企發展商,該行首予其「買入」評級,目標價26元。
該行認為,與其他國企發展商相比,建發國際以更好的增長前景跑贏,未來三年合同銷售複合年均增長率料達14%,純利複合年均增長率料達18%。該行指公司地域擴張潛力大,且更為積極的土地收購,均支持公司盈利增長。
此外,該行指建發國際與其他可能缺乏管理層激勵措施的國企不同,公司向管理層授予7.8%的激勵股份。
該行指建發國際受惠內地放寬樓市限購的國策,估算二線城市潛在放寬限購可提振該公司合約銷售達6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.